Research: VATASSERY and colleagues

Listed in Issue 36

Abstract

VATASSERY and colleagues, GRECC, VA Medical Center, Department of Psychiatry, University of Minnesota, Minneapolis 55417 USA studied the association of alpha-tocopherol (vitamin E) concentrations and Parkinson's disease.

Background

Methodology

The concentration of alpha-tocopherol was determined in the cerebral spinal fluid (CSF) in patients with early untreated Parkinson's disease. Patients received 2,000 IU vitamin E orally each day.

Results

Following treatment, concentrations increased significantly by 76+%. Net increases in CSF alpha-tocopherol concentrations following treatment showed a significant positive correlation with the number of days of vitamin E intake.

Conclusion

High-dose vitamin E treatment results in an elevation of vitamin E CSF levels and possibly brain vitamin E levels.

References

Vatassery GT et al. Alpha tocopherol in CSF of subjects taking high-dose vitamin E in the DATATOP study. Parkinson Study Group. Neurology 50(6): 1900-2. June 1998.

Munro Hall Clinic 2019

IJCA 2018 New Skyscraper

Scientific and Medical Network 2021

Cycle India 2020

Walk on the Wide Side Trek Kenya 2020

Big Heart Bike Ride South Africa 2020

top of the page